ARTELO BIOSCIENCES, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
ARTELO BIOSCIENCES, INC. (ARTL) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $51.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2024-03-25
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-03-31 was $49.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-12-31 was $134.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-09-30 was -$212.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-06-30 was -$112.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $51.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$236.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$59.00K.
- ARTELO BIOSCIENCES, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$46.00K, a 162.16% decline from fiscal 2020.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 4 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $51.00K 10-K · filed 2024-03-25 | ||||||
| 2023-03-31 | $49.00K 10-Q · filed 2023-05-11 | $183.00K derived: sum of 2 quarters · filed 2024-03-25 | -$29.00K derived: sum of 3 quarters · filed 2024-03-25 | -$141.00K derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2022-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$78.00K derived: sum of 2 quarters · filed 2024-03-25 | -$190.00K derived: sum of 3 quarters · filed 2024-03-25 | -$236.00K 10-K · filed 2024-03-25 | |||
| 2022-09-30 | -$212.00K 10-Q · filed 2022-11-08 | -$324.00K derived: sum of 2 quarters · filed 2022-11-08 | -$370.00K 10-Q · filed 2022-11-08 | -$401.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2022-06-30 | -$112.00K 10-Q · filed 2022-11-08 | -$158.00K 10-Q · filed 2022-08-09 | -$189.00K derived: sum of 3 quarters · filed 2023-05-11 | ||||
| 2022-03-31 | -$46.00K 10-Q · filed 2023-05-11 | -$77.00K derived: sum of 2 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$36.00K 10-K · filed 2023-03-31 | -$59.00K 10-K · filed 2023-03-31 | ||||
| 2021-11-30 | -$41.00K 10-Q · filed 2022-01-12 | ||||||
| 2021-09-30 | -$12.00K 10-Q · filed 2022-11-08 | -$28.00K 10-Q · filed 2022-11-08 | |||||
| 2021-08-31 | -$31.62K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$46.00K 10-K · filed 2023-03-31 | |||||
| 2021-06-30 | -$18.00K 10-Q · filed 2022-11-08 | -$16.00K 10-Q · filed 2022-08-09 | |||||
| 2021-05-31 | $1.48K 10-Q · filed 2021-07-12 | -$14.38K 10-Q · filed 2021-07-12 | |||||
| 2021-03-31 | $2.00K 10-Q · filed 2022-11-08 | ||||||
| 2021-02-28 | $373.00 10-Q · filed 2021-07-12 | -$15.86K 10-Q · filed 2021-04-13 | -$1.94K derived: sum of 3 quarters · filed 2022-03-21 | $32.61K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-12-31 | -$23.00K 10-KT · filed 2022-03-21 | ||||||
| 2020-11-30 | -$16.00K 10-Q · filed 2022-01-12 | -$16.23K 10-Q · filed 2021-01-14 | -$2.31K derived: sum of 2 quarters · filed 2022-03-21 | $32.24K derived: sum of 3 quarters · filed 2022-03-21 | $41.66K derived: sum of 4 quarters · filed 2022-03-21 | ||
| 2020-08-31 | $13.69K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | $48.24K derived: sum of 2 quarters · filed 2022-03-21 | $57.66K derived: sum of 3 quarters · filed 2022-03-21 | $74.00K 10-KT · filed 2022-03-21 | $73.57K 10-K · filed 2020-11-04 | ||
| 2020-05-31 | $34.55K 10-Q · filed 2021-07-12 | $43.97K derived: sum of 2 quarters · filed 2021-07-12 | $60.31K 10-Q · filed 2021-07-12 | $60.73K derived: sum of 4 quarters · filed 2021-07-12 | |||
| 2020-02-29 | $9.42K 10-Q · filed 2021-07-12 | $25.76K 10-Q · filed 2021-04-13 | $26.18K derived: sum of 3 quarters · filed 2021-07-12 | $26.95K derived: sum of 4 quarters · filed 2021-07-12 | |||
| 2019-11-30 | $16.34K 10-Q · filed 2021-07-12 | $16.77K derived: sum of 2 quarters · filed 2021-07-12 | $17.54K derived: sum of 3 quarters · filed 2021-07-12 | $13.93K derived: sum of 4 quarters · filed 2021-07-12 | |||
| 2019-08-31 | $421.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-04 | $1.19K derived: sum of 2 quarters · filed 2020-11-04 | -$2.41K derived: sum of 3 quarters · filed 2020-11-04 | $2.47K 10-K · filed 2020-11-04 | |||
| 2019-05-31 | $771.00 10-Q · filed 2020-07-13 | -$2.83K derived: sum of 2 quarters · filed 2020-07-13 | $2.05K 10-Q · filed 2020-07-13 | $1.46K derived: sum of 4 quarters · filed 2020-07-13 | |||
| 2019-02-28 | -$3.61K 10-Q · filed 2020-07-13 | $1.28K 10-Q · filed 2020-04-13 | $686.00 derived: sum of 3 quarters · filed 2020-07-13 | -$9.38K derived: sum of 4 quarters · filed 2020-07-13 | |||
| 2018-11-30 | $4.89K 10-Q · filed 2020-07-13 | $4.29K derived: sum of 2 quarters · filed 2020-07-13 | -$5.77K derived: sum of 3 quarters · filed 2020-07-13 | -$7.02K derived: sum of 4 quarters · filed 2020-07-13 | |||
| 2018-08-31 | -$596.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | -$10.66K derived: sum of 2 quarters · filed 2019-12-18 | -$11.91K derived: sum of 3 quarters · filed 2019-12-18 | -$12.94K 10-K/A · filed 2019-12-18 | |||
| 2018-05-31 | -$10.06K 10-Q · filed 2019-07-15 | -$11.32K derived: sum of 2 quarters · filed 2019-07-15 | -$12.34K 10-Q · filed 2019-07-15 | ||||
| 2018-02-28 | -$1.25K 10-Q · filed 2019-07-15 | -$2.28K 10-Q · filed 2019-04-15 | |||||
| 2017-11-30 | -$1.02K 10-Q · filed 2019-07-15 | ||||||
| 2017-08-31 | $657.00 10-K · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |